Biggest Short Squeeze Stocks Of The Week: Biotech Stocks Dominate, A Bitcoin-Related Stock Moves Up Leaderboard

Zinger Key Points
  • A look at top short squeeze candidates for the week.
  • A Bitcoin-related stock continues to rank high on the leaderboard.
Loading...
Loading...

Potential short squeeze plays gained steam in 2021, continued throughout 2022 and remained a focus of traders looking for the next big move.

High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.

Here's a look at the top five short squeeze candidates for the week based on the Fintel short squeeze leaderboard.

  • 1. Ambrx Biopharma Inc AMAM: The biotech stock topped the short squeeze leaderboard for a second straight week.

    Data shows 55.8% of the float is short as of Monday. The cost to borrow on shares is 24.6%.

    While both figures were down from last week's report, the stock remained highly volatile and among the most shorted stocks.

  • 2. Aytu Biopharma Inc AYTU: The biotech stock jumped into the top five short squeeze candidates for the week.

    Data showed 19.8% of the float short and a cost to borrow of 104.6%.

  • 3. Bitcoin Depot Inc BTM: The crypto ATM company that offered services for leading coins like Bitcoin BTC/USD continued to rank high among shorted stocks.

    The company moved up one position from fourth place to third place.

    Data showed 15.2% of the float short and a cost to borrow of 25.1%. Shares of Bitcoin Depot were down 75% year-to-date in 2023.

  • 4. Klaviyo Inc KVYO: The technology and software-as-a-service stock ranked fourth on the short squeeze leaderboard, moving up 92 positions from the prior week.

    Data showed 83.3% of the float short, which was the second-highest figure reported by Fintel on the leaderboard. The cost to borrow on shares is 5.6%.

    The company went public in September 2023.
  • 5. Safety Shot Inc SHOT: The beverage company ranked fifth on this week's short squeeze leaderboard, moving up nine positions.

    Data showed 20.7% of the float short and a cost to borrow of 78.4%. Shares of Safety Shot were up 137% year-to-date in 2023.


    Read Next: Benzinga's ‘Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Don't Talk About Yet
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: BiotechShort IdeasTop StoriesTechTrading IdeasFintelFintel short squeezeShort Squeezeshort squeeze candidatesShort squeeze ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...